Valproate-acid-induced cutaneous leukocytoclastic vasculitis

Psychiatria Danubina

Volumn 24, Issue 2, 2012, Pages 215-218

  Lasić, Davor ^a   Ivanišević, Ranka ^a   Uglešić, Boran ^a   Cvitanović, Marija Žuljan ^a   Glučina, Dubravka ^a   Hlevnjak, Ivana ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALLOPURINOL; ANTICONVULSIVE AGENT; BENZYLTHIOURACIL; CARBIMAZOLE; CLONAZEPAM; CLOZAPINE; CORTICOSTEROID; DESLORATADINE; ETANERCEPT; HYDRALAZINE; INFLIXIMAB; LAMOTRIGINE; LEVAMISOLE; MINOCYCLINE; PENICILLAMINE; PHENYTOIN; PREDNISOLONE; PREDNISONE; RANITIDINE; SALAZOSULFAPYRIDINE; THIAMAZOLE; THIORIDAZINE; THYROGLOBULIN ANTIBODY; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; EOSINOPHILIA; EPILEPSY; FEMALE; HEMATURIA; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; MICROSCOPY; PAPULE; PURPURA; RASH; SKIN BIOPSY; SKIN DEFECT; THROMBOCYTOPENIA; URINALYSIS; CHEMICALLY INDUCED DISORDER;

ADULT; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; VALPROIC ACID; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS;

EID: 84864865593     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sepp N. Vasculitis. In: Burgdorf WHC, Plewig G, Wolff HH, Landthaler M, editors. Braun-Falco's dermatology. 3th ed. Heidelberg: Springer Medizin Verlag; 2009. pp. 871-898.
2. Kevil CG, Bullard DC. Roles of leukocyte/endothelial cell adhesion molecules in the pathogenesis of vasculitis. Am J Med. 1999; 106:677-87.
3. Gonzalez-Gay MA, Garcia-Porrua C, Pujol RM. Clinical approach to cutaneous vasculitis. Curr Opin Rheumatol 2005; 17:56-61
4. Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 2002; 36:130-47.
5. Lange-Asschenfeldt C, Grohmann R, Lange-Asschenfeldt B, Engel RR, Rüther E, Cordes J. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program. J Clin Psychiatry 2009; 70:1258-65. Epub 2009 Jun 16.
6. Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol 2008; 9:71-92.
7. Carlson JA, Cavaliere LF, Grant-Kels JM. Cutaneous vasculitis: diagnosis and management. Clin Dermatol 2006; 24:414-29.
8. Carlson JA, Chen KR. Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes. Am J Dermatopathol 2006; 28:486-506.
9. Radic M, Martinovic Kaliterna1 D, Radic J. Drug-induced vasculitis: a clinical and pathological review. Neth J Med 2012; 70:12-17.
10. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology. 1997; 49:542-6.
11. Ha YJ, Han YJ, Choi YW, Myung KB, Choi HY. Sibutramine (reductil®)-induced cutaneous leukocytoclastic vasculitis: a case report. Ann Dermatol. 2011; 23:544-7. Epub 2011 Nov 3.
12. Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol 2005; 7:504-528.
13. Lasić D, Cvitanović MZ, Uglešić B, Višić V, Hlevnjak I. Exanthema medicamentosum as a side effect of promazine. Psychiatr Danub 2011; 23:194-7.